Modeling Pathogenesis of Huntington’s Disease with Inducible Neuroprogenitor Cells

被引:0
作者
G. Dong
J. M. Ferguson
A. J. Duling
R. G. Nicholas
D. Zhang
K. Rezvani
S. Fang
M. J. Monteiro
S. Li
X-J. Li
H. Wang
机构
[1] University of South Dakota,Division of Basic Biomedical Sciences, Sanford School of Medicine
[2] University of South Dakota,Department of Biology
[3] University of Maryland,Center for Biomedical Engineering and Technology
[4] Emory University School of Medicine,Department of Human Genetics
来源
Cellular and Molecular Neurobiology | 2011年 / 31卷
关键词
Huntington’s disease; Pathogenesis; Huntingtin; Polyglutamine; Neuron; Neuroprogenitor;
D O I
暂无
中图分类号
学科分类号
摘要
Huntington’s disease (HD) is caused by an abnormal expansion of CAG trinucleotide repeats encoding polyglutamine (polyQ) in the first exon of the huntingtin (htt) gene. Despite considerable efforts, the pathogenesis of HD remains largely unclear due to a paucity of models that can reliably reproduce the pathological characteristics of HD. Here, we report a neuronal cell model of HD using the previously established tetracycline regulated rat neuroprogenitor cell line, HC2S2. Stable expression of enhanced green fluorescence protein tagged htt exon 1 (referred to as 28Q and 74Q, respectively) in the HC2S2 cells did not affect rapid neuronal differentiation. However, compared to the cells expressing wild type htt, the cell line expressing mutant htt showed an increase in time-dependent cell death and neuritic degeneration, and displayed increased vulnerability to oxidative stress. Increased protein aggregation during the process of neuronal aging or when the cells were exposed to oxidative stress reagents was detected in the cell line expressing 74Q but not in its counterpart. These results suggest that the neuroprogenitor cell lines mimic the major neuropathological characteristics of HD and may provide a useful tool for studying the neuropathogenesis of HD and for high throughput screening of therapeutic compounds.
引用
收藏
页码:737 / 747
页数:10
相关论文
共 50 条
  • [31] Biological Aging and the Cellular Pathogenesis of Huntington's Disease
    Machiela, Emily
    Southwell, Amber L.
    JOURNAL OF HUNTINGTONS DISEASE, 2020, 9 (02) : 115 - 128
  • [32] From Pathogenesis to Therapeutics: A Review of 150 Years of Huntington's Disease Research
    Jiang, Andrew
    Handley, Renee R.
    Lehnert, Klaus
    Snell, Russell G.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (16)
  • [33] The role of post-translational modifications of huntingtin in the pathogenesis of Huntington's disease
    Wang, Yan
    Lin, Fang
    Qin, Zheng-Hong
    NEUROSCIENCE BULLETIN, 2010, 26 (02) : 153 - 162
  • [34] Inducible PC12 cell model of Huntington's disease shows toxicity and decreased histone acetylation
    Igarashi, S
    Morita, H
    Bennett, KM
    Tanaka, Y
    Engelender, S
    Peters, MF
    Cooper, JK
    Wood, JD
    Sawa, A
    Ross, CA
    NEUROREPORT, 2003, 14 (04) : 565 - 568
  • [35] Dermal Fibroblast Cell Line from a Patient with the Huntington's Disease as a Promising Model for Studying Disease Pathogenesis: Production and Characterization
    Kraskovskaya, Nina
    Koltsova, Anna
    Parfenova, Polina
    Shatrova, Alla
    Yartseva, Natalya
    Nazarov, Vladimir
    Devyatkina, Ekaterina
    Khotin, Mikhail
    Mikhailova, Natalia
    BIOCHEMISTRY-MOSCOW, 2024, 89 (07) : 1239 - 1250
  • [36] Molecular diagnosis in Huntington's disease
    Alejandra Rosales-Reynoso, Mnica
    Barros-Nunez, Patricio
    GACETA MEDICA DE MEXICO, 2008, 144 (03): : 271 - 273
  • [37] Structural Mapping of Protein Aggregates in Live Cells Modeling Huntington's Disease
    Guo, Zhongyue
    Chiesa, Giulio
    Yin, Jiaze
    Sanford, Adam
    Meier, Stefan
    Khalil, Ahmad S.
    Cheng, Ji-Xin
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2024, 63 (35)
  • [38] Role of thiamine in Huntington's disease pathogenesis: In vitro studies
    Gruber-Bzura, Beata M.
    Krzyszton-Russjan, Jolanta
    Bubko, Irena
    Syska, Jaroslaw
    Jaworska, Malgorzata
    Zmyslowski, Adam
    Roslon, Magdalena
    Drozd, Janina
    Drozd, Ewa
    Majorczyk, Edyta
    Anuszewska, Elzbieta L.
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 26 (05): : 751 - 760
  • [39] Huntington's disease
    Davies, S
    Ramsden, DB
    JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY, 2001, 54 (06): : 409 - 413
  • [40] Huntington’s Disease
    Marcy E. MacDonald
    Silvia Gines
    James F. Gusella
    Vanessa C. Wheeler
    NeuroMolecular Medicine, 2003, 4 : 7 - 20